Abstract
Resources for healthcare are scarce, so choices need to be made about how to get the best possible health outcomes given the available resources. Economic evaluation is often integrated into broader evaluation studies (e.g. randomised trials of interventions), in which specific measures of costs and economically relevant outcomes are added. The building blocks of economic evaluation include the choice of framework (e.g. cost-effectiveness or cost-utility analysis), decision-making perspectives, time horizons, discounting of costs and outcomes and decision analytical models (e.g. decision tree or Markov model). Economic evaluation frequently uses specific (quantitative) methods for estimating the efficiency of interventions, such as incremental cost-effectiveness ratios. In addition, economic evaluation in HSR explores the variation of costs and efficiency across healthcare providers and underlying factors.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Attema, A. E., Brouwer, W. B. F., Claxton, K. (2018). Discounting in Economic Evaluations. Pharmacoeconomics, 36(7), 745–758.
Bach, P.B. (2009). Limits on Medicare's ability to control rising spending on cancer drugs. N Engl J Med, 360(6), 626–33.
Birch, S. & Donaldson, C. (1987). Applications of cost-benefit analysis to health care. Departures from welfare economic theory. J Health Econ, 6(3), 211–25.
Birch, S. & Gafni, A. (2003): Economics and the evaluation of health care programmes: Generalisability of methods and implications for generalisability of results. Health Policy, 64(2), 207–219.
Birch, S. & Gafni A. (2007). Economists’ dream or nightmare? Maximising health gains from available resources using the NICE guidelines. Health Economics, Policy and Law, 2(Pt 2), 193–202.
Brazier, J., Roberts, J., Tsuchiya, A., et al. (2004). A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ, 13(9), 873–84.
Drummond, M. F., Sculpher, M. J., Claxton, K., et al. (2015). Methods for the Economic Evaluation of Health Care Programmes (4th ed.). Oxford University Press.
Eckert, T., Wronski, P., Bongartz, M., et al. (2021). Cost-Effectiveness and Cost-Utility of a Home-Based Exercise Program in Geriatric Patients with Cognitive Impairment. Gerontology, 67(2), 220–232.
Harmsen M., Adang E., Wolters R.J., et al. (2009). Prevention of renal failure in children with urinary tract infections: a literature review and economic analysis. Value Health;12:466–72.
Jain, R., Grabner, M., & Onukwugha, E. (2011). Sensitivity analysis in cost-effectiveness studies: from guidelines to practice. Pharmacoeconomics, 29(4), 297–314.
Jevdjevic, M., Trescher, A-L., Rovers, M. et al. (2019). The caries-related cost and effects of a tax on sugar-sweetened beverages. Public Health, 169, 125–132.
Listl, S., Grytten, J. I., Birch, S. (2019). What is health economics? Community Dent Health, 36(4), 262–274.
Peacock, S. J., Mitton, C., Ruta, D., et al. (2010). Priority setting in healthcare: towards guidelines for the program budgeting and marginal analysis framework. Expert Rev Pharmacoecon Outcomes Res, 10(5), 539–552.
Petrou, S. & Gray, A. (2011). Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting. BMJ, 342, d1766.
Å pacÃrová, Z., Epstein, D., GarcÃa-Mochón, L., et al. (2020). A general framework for classifying costing methods for economic evaluation of health care. Eur J Health Econ, 21, 529–542.
Stinnett, A. A. & Mullahy, J. (1998). Net Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis [Supplemental material]. Medical Decision Making, 18, 68–80.
Sullivan, S. D., Mauskopf, J. A., Augustovski, F., et al. (2014). Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health, 17(1), 5–14.
Timmermans, M. J. C., van den Brink, G. T., van Vught, A. J. A. H, et al. (2017). The involvement of physician assistants in inpatient care in hospitals in The Netherlands: a cost-effectiveness analysis. BMJ Open, 7(7), e016405.
Williams, A. (1983). The Economic Role of Health Indicators. In G. Teeling Smith (Ed.), Measuring the Social Benefits of Medicine (pp. 63-67). Office of Health Economics.
Wolters R., Grol R., Schermer T., et al. (2006). Improving initial management of lower urinary tract symptoms in primary care: Costs and patient outcomes. Scandinavian Journal of Urology and Nephrology; 40:300–306.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Listl, S., Wensing, M. (2023). Economic Evaluation in Health Services Research. In: Wensing, M., Ullrich, C. (eds) Foundations of Health Services Research. Springer, Cham. https://doi.org/10.1007/978-3-031-29998-8_15
Download citation
DOI: https://doi.org/10.1007/978-3-031-29998-8_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-29997-1
Online ISBN: 978-3-031-29998-8
eBook Packages: MedicineMedicine (R0)